Highland Capital Management Fund Advisors, L.P. Amgen Inc Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $427,576 - $473,011	-1,950 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $387,816 - $443,820	1,950 New	1,950 $439,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $2.16 Million - $2.58 Million	-10,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $2.35 Million - $2.61 Million	10,000 New	10,000 $2.54 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $552,187 - $732,351	-3,030 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $573,306 - $736,896	3,030 New	3,030 $730,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account